OAR@UM: Browsing OAR@UM

Browsing by Author Shoemake, Claire

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 6 to 25 of 29 < previous next >

Issue Date	Title	Author(s)
2015	The design and optimisation of novel human dihydrofolate reductase inhibitors for the management of proliferative disease	Portelli, Graziella; Shoemake, Claire
2016	Design and optimisation of novel Huperzine A analogues capable of modulating the acetylcholinesterase receptor for the management of Alzheimer’s disease	Bonavia, Sara; Shoemake, Claire
2017	Design and optimization of K-Ras protein inhibitors as anticancer agents using deltarasin as a case study	Woods, Martina; Shoemake, Claire
2017	Design of novel compounds with the potential of dual PPARγ/α modulation for the management of metabolic syndrome	Ellul, Claire; Shoemake, Claire
2013-08	Drug design of de novo designed molecules at the peroxisome proliferator activated receptor	Portelli, Stephanie; Shoemake, Claire; Azzopardi, Lilian M.
2013-08	Drug design of molecules binding to the 5-HT receptor using a bioisosteric approach	Schembri, Maria; Shoemake, Claire; Azzopardi, Lilian M.
2014	Drug design of novel molecules using a bioisosteric and de novo techniques - a comparison	Schembri, Maria; Shoemake, Claire; Sant Fournier, Marianne
2014-05-27	The effects of Anabasine and the alkaloid extract of Nicotiana glauca on Lepidopterous Larvae	Zammit, Michelle; Shoemake, Claire; Attard, Everaldo; Azzopardi, Lilian M.
2016	Evaluation and Optimization of In Silico Designed PDE4B Modulators	Attard, Daniel; Shoemake, Claire; Vella, John; Żmudzki, Paweł; Chłoń-Rzepa, Grażyna; Wyska, Elżbieta
2017	Evaluation and optimization of in silico designed Sphingosine-1-Phosphate (S1P) Receptor Subtype 1 modulators for the management of multiple sclerosis	Gusman, Daphne H.; Shoemake, Claire
2016	Evaluation and optimization of in silico designed β-Secretase modulators for the treatment of "Alzheimer's Disease"	Borg, Luke; Xuereb, Keith; Shoemake, Claire
2013-08	Evaluation of a molecular database of drugs used to target the endocrine system	Borg, Denise; Shoemake, Claire; Azzopardi, Lilian M.
2015	Generating a homology model of the human M1 muscarinic receptor and the design of cognate modulators at this locus for the management of Alzheimer’s disease	Bugeja, Neil J.; Shoemake, Claire
2016-07	Identification of lead molecules capable of the simultaneous agonism of the PPARƴ and PPARα subtypes for the dual management of diabetes mellitus and dyslipidaemia	Ellul, Claire; Shoemake, Claire
2014	In silico identification of a potentially novel binding modality for 1,3-dicarbonyl compounds having 2(3h)-benzazolonic heterocycles within the pparγ ligand binding pocket : a de novo design study	Portelli, Stephanie; Shoemake, Claire; Azzopardi, Lilian M.
2009-11	Investigating the angiotensin converting enzyme (ACE) inhibiting properties of naturally occurring terpenes using in silico models	Mifsud, S. J.; Shoemake, Claire; Attard, Everaldo; Sant Fournier, Marianne; Azzopardi, Lilian M.
2013	Investigating the anti-oestrogenic effect of p-Synephrine and de novo design of oestrogen receptor modulating molecules	Pace Bardon, C.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2013-02-28	Investigative study on the angiotensin converting enzyme (ACE) inhibiting properties of the terpenoid extract of Crataegus monogyna using in silico models	Farrugia, Deborah Louise; Shoemake, Claire; Attard, Everaldo; Azzopardi, Lilian M.; Mifsud, S. J.
2013	Labelling and testing of foods designated as suitable for diabetic and low calorie diets	Cordina, Jakov; Shoemake, Claire; Azzopardi, Lilian M.
2013	De novo design of non-steroidal oestrogen receptor modulating molecules using maltanedienol as a lead molecule	Shoemake, Claire; Azzopardi, Lilian M.; Saliba, Charles; Gutierrez, Gilles; Cassar, Maria

Showing results 6 to 25 of 29 < previous next >